Merck & Co Unusual Options Activity For September 23
Merck & Co Unusual Options Activity For September 23
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $110.0 and $125.0 for Merck & Co, spanning the last three months.Deep-pocketed investors have adopted a bearish approach towards Merck & Co (NYSE:MRK), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRK usually suggests something big is about to happen.
富有的投資者對美國默沙東（紐交所: MRK）採取了看淡的態度，這是市場參與者不應忽視的。我們在Benzinga追蹤公開期權記錄發現了這一重大舉動。這些投資者的身份仍然是未知的，但在MRK上這樣的重大舉動通常意味着即將發生重大事情。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Merck & Co. This level of activity is out of the ordinary.
我們從今天Benzinga的期權掃描器突出顯示的11個特殊期權活動中獲得了這些信息。這種活動水平是不尋常的。
The general mood among these heavyweight investors is divided, with 45% leaning bullish and 54% bearish. Among these notable options, 2 are puts, totaling $84,071, and 9 are calls, amounting to $500,344.
這些大額投資者中普遍情緒分爲兩派，45%傾向看好，54%傾向看淡。在這些引人注目的期權中，有2個看跌，總額爲84071美元，有9個看漲，金額達到500344美元。
Predicted Price Range
預測價格區間
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $110.0 and $125.0 for Merck & Co, spanning the last three months.
在評估交易量和未平倉合約後，很明顯主要的市場操縱者正專注於美國默沙東的價格區間，介於110.0美元和125.0美元之間，在過去三個月內。
Analyzing Volume & Open Interest
分析成交量和未平倉合約
In today's trading context, the average open interest for options of Merck & Co stands at 3469.29, with a total volume reaching 7,958.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Merck & Co, situated within the strike price corridor from $110.0 to $125.0, throughout the last 30 days.
在今天的交易環境中，美國默沙東的期權平均未平倉合約爲3469.29，總成交量達到7958.00。附圖描述了過去30天內，在美國默沙東高價交易的看漲和看跌期權成交量及未平倉合約的變化，位於110.0美元至125.0美元的行權價格走廊內。
Merck & Co 30-Day Option Volume & Interest Snapshot
默沙東30天期權成交量及持倉量快照
Significant Options Trades Detected:
檢測到重大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | CALL | TRADE | BEARISH | 10/18/24 | $1.74 | $1.65 | $1.68 | $117.00 | $120.4K | 0 | 1.0K |
| MRK | CALL | SWEEP | BEARISH | 11/15/24 | $2.77 | $2.72 | $2.72 | $120.00 | $98.3K | 4.8K | 64 |
| MRK | CALL | SWEEP | BULLISH | 10/18/24 | $0.76 | $0.72 | $0.75 | $120.00 | $67.2K | 9.8K | 998 |
| MRK | CALL | TRADE | BEARISH | 06/20/25 | $9.95 | $9.85 | $9.89 | $115.00 | $49.4K | 298 | 4 |
| MRK | PUT | SWEEP | BEARISH | 11/15/24 | $3.0 | $2.98 | $2.98 | $115.00 | $45.2K | 4.5K | 468 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | 看漲 | 交易 | 看淡 | 10/18/24 | $1.74 | $1.65 | $1.68 | $117.00 | $120.4K | 0 | 1.0K |
| MRK | 看漲 | SWEEP | 看淡 | 11/15/24 | $2.77 | 2.72美元 | 2.72美元 | $120.00 | $98.3K | 4.8千 | 64 |
| MRK | 看漲 | SWEEP | 看好 | 10/18/24 | $0.76 | 0.72美元 | 0.75美元 | $120.00 | $67.2K | 9.8千 | 998 |
| MRK | 看漲 | 交易 | 看淡 | 06/20/25 | $9.95 | $9.85 | $9.89 | $115.00 | 49,400 美元 | 298 | 4 |
| MRK | 看跌 | SWEEP | 看淡 | 11/15/24 | $3.0 | $2.98 | $2.98 | $115.00 | $45.2千 | 4.5K | 468 |
About Merck & Co
關於默沙東
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
默沙東生產多種藥品，治療多種領域的疾病，包括心代謝症、癌症和感染。在癌症領域，該公司的免疫腫瘤學平台正在成爲總銷售額的主要貢獻者。該公司還具有實質性的疫苗業務，包括預防兒童疾病以及人類乳頭瘤病毒（HPV）治療。此外，默沙東出售與動物健康相關的藥品。從地理角度來看，公司銷售額的近一半來自於美國境內。
Current Position of Merck & Co
默沙東目前的位置
- With a trading volume of 3,262,924, the price of MRK is down by -1.08%, reaching $115.9.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 38 days from now.
- MRk的成交量爲3,262,924，價格下跌-1.08%，達到115.9美元。
- 目前的RSI值表明該股票目前處於超買和超賣之間的中立狀態。
- 下一份收益報告將於38天后發佈。
Expert Opinions on Merck & Co
專家對默沙東的意見
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $155.0.
在過去30天中，共有2位專業分析師對這隻股票發表了意見，設定了平均目標價格爲$155.0。
Unusual Options Activity Detected: Smart Money on the Move
檢測到期權異動：智慧資金在行動。
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $155.* An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $155.
Benzinga Edge的飛凡期權委員會在市場變動之前發現潛在的潛力股。查看大資金在您最喜歡的股票上的倉位。點擊這裏進行訪問。*反映擔憂，Cantor Fitzgerald的分析師將評級下調爲增持，並設定了新的目標價爲$155。* Cantor Fitzgerald的分析師已將其評級下調爲增持，調整價格目標至$155。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts.
期權交易涉及更大的風險，但也提供了更高的利潤潛力。精明的交易者通過持續教育、戰略性交易調整、利用各種因子和關注市場動態來降低這些風險。使用 Benzinga Pro 獲取默沙東的最新期權交易實時警報。
譯文內容由第三人軟體翻譯。
